These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 32311432)
1. The treatment of recurrent conjunctival and corneal intraepithelial neoplasia with interferon alfa-2b and retinoic acid: ~9 years' follow-up on tumor control. Ip MH; Tat L; Coroneo MT Ocul Surf; 2020 Jul; 18(3):354-359. PubMed ID: 32311432 [TBL] [Abstract][Full Text] [Related]
2. Treatment of conjunctival and corneal epithelial neoplasia with retinoic acid and topical interferon alfa-2b: long-term follow-up. Krilis M; Tsang H; Coroneo M Ophthalmology; 2012 Oct; 119(10):1969-73. PubMed ID: 22704834 [TBL] [Abstract][Full Text] [Related]
3. Treatment of recurrent corneal and conjunctival intraepithelial neoplasia with topical interferon alfa 2b. Boehm MD; Huang AJ Ophthalmology; 2004 Sep; 111(9):1755-61. PubMed ID: 15350333 [TBL] [Abstract][Full Text] [Related]
4. Long-term follow-up of conjunctival and corneal intraepithelial neoplasia treated with topical interferon alfa-2b. Schechter BA; Koreishi AF; Karp CL; Feuer W Ophthalmology; 2008 Aug; 115(8):1291-6, 1296.e1. PubMed ID: 18187195 [TBL] [Abstract][Full Text] [Related]
5. Long-term results of topical mitomycin C 0.02% for primary and recurrent conjunctival-corneal intraepithelial neoplasia. Ballalai PL; Erwenne CM; Martins MC; Lowen MS; Barros JN Ophthalmic Plast Reconstr Surg; 2009; 25(4):296-9. PubMed ID: 19617789 [TBL] [Abstract][Full Text] [Related]
6. Perilesional and topical interferon alfa-2b for conjunctival and corneal neoplasia. Vann RR; Karp CL Ophthalmology; 1999 Jan; 106(1):91-7. PubMed ID: 9917787 [TBL] [Abstract][Full Text] [Related]
7. Regression of presumed primary conjunctival and corneal intraepithelial neoplasia with topical interferon alpha-2b. Schechter BA; Schrier A; Nagler RS; Smith EF; Velasquez GE Cornea; 2002 Jan; 21(1):6-11. PubMed ID: 11805499 [TBL] [Abstract][Full Text] [Related]
8. Topical interferon alfa-2b for management of ocular surface squamous neoplasia in 23 cases: outcomes based on American Joint Committee on Cancer classification. Shah SU; Kaliki S; Kim HJ; Lally SE; Shields JA; Shields CL Arch Ophthalmol; 2012 Feb; 130(2):159-64. PubMed ID: 22332208 [TBL] [Abstract][Full Text] [Related]
9. A case of conjunctiva-cornea intraepithelial neoplasia successfully treated with topical mitomycin C and interferon alfa-2b in cycles. Di Pascuale MA; Espana EM; Tseng SC Cornea; 2004 Jan; 23(1):89-92. PubMed ID: 14701965 [TBL] [Abstract][Full Text] [Related]
11. Treatment of conjunctival and corneal intraepithelial neoplasia with topical interferon alpha-2b. Karp CL; Moore JK; Rosa RH Ophthalmology; 2001 Jun; 108(6):1093-8. PubMed ID: 11382635 [TBL] [Abstract][Full Text] [Related]
12. Diagnosis and management of conjunctival and corneal intraepithelial neoplasia using ultra high-resolution optical coherence tomography. Shousha MA; Karp CL; Perez VL; Hoffmann R; Ventura R; Chang V; Dubovy SR; Wang J Ophthalmology; 2011 Aug; 118(8):1531-7. PubMed ID: 21507486 [TBL] [Abstract][Full Text] [Related]
13. Topical interferon alfa in the treatment of conjunctival melanoma and primary acquired melanosis complex. Finger PT; Sedeek RW; Chin KJ Am J Ophthalmol; 2008 Jan; 145(1):124-129. PubMed ID: 17981257 [TBL] [Abstract][Full Text] [Related]
14. Topical interferon alpha-2B topic as the first therapeutic option in a clinical case of conjunctival intraepithelial neoplasia. Pagán Carrasco S; Arranz Maestro D Arch Soc Esp Oftalmol; 2017 Sep; 92(9):442-446. PubMed ID: 28292536 [TBL] [Abstract][Full Text] [Related]
15. Topical 0.002% mitomycin C for the treatment of conjunctival-corneal intraepithelial neoplasia and squamous cell carcinoma. Prabhasawat P; Tarinvorakup P; Tesavibul N; Uiprasertkul M; Kosrirukvongs P; Booranapong W; Srivannaboon S Cornea; 2005 May; 24(4):443-8. PubMed ID: 15829803 [TBL] [Abstract][Full Text] [Related]
16. Comparison of Topical 5-Fluorouracil and Interferon Alfa-2b as Primary Treatment Modalities for Ocular Surface Squamous Neoplasia. Venkateswaran N; Mercado C; Galor A; Karp CL Am J Ophthalmol; 2019 Mar; 199():216-222. PubMed ID: 30471241 [TBL] [Abstract][Full Text] [Related]
17. Mitomycin C treatment for conjunctival-corneal intraepithelial neoplasia: a multicenter experience. Frucht-Pery J; Sugar J; Baum J; Sutphin JE; Pe'er J; Savir H; Holland EJ; Meisler DM; Foster JA; Folberg R; Rozenman Y Ophthalmology; 1997 Dec; 104(12):2085-93. PubMed ID: 9400769 [TBL] [Abstract][Full Text] [Related]
18. Topical Interferon α-2b as a Single Therapy for Primary Ocular Surface Squamous Neoplasia. Kusumesh R; Ambastha A; Sinha B; Kumar R Asia Pac J Ophthalmol (Phila); 2015; 4(5):279-82. PubMed ID: 26176194 [TBL] [Abstract][Full Text] [Related]
19. [Interferon alfa-2b treatment in selected cases of recurrent conjunctival intraepithelial neoplasia]. Toledano Fernández N; García Sáenz S; Díaz Valle D; Arteaga Sánchez A; Segura Bedmar M; Lorenzo Giménez S; Cortés Lambea L Arch Soc Esp Oftalmol; 2003 May; 78(5):265-71. PubMed ID: 12789630 [TBL] [Abstract][Full Text] [Related]
20. Treatment of CIN with retinoic acid and topical interferon alfa-2b. Huerva V Ophthalmology; 2013 Aug; 120(8):e55. PubMed ID: 23916085 [No Abstract] [Full Text] [Related] [Next] [New Search]